Tobacco Company Is Making COVID-19 Vaccine

By | April 14, 2020

British American Tobacco (BAT) has joined the race to develop a vaccine for COVID-19, with plans to potentially manufacture 1 million to 3 million doses of vaccine per week. While vaccine development typically takes years, and even then has a poor track record when it comes to safety testing, BAT’s potential COVID-19 vaccine is already in preclinical testing.

Further, BAT, which is working in conjunction with its U.S. biotech subsidiary, Kentucky BioProcessing (KBP), stated that if testing goes well, and “with the right partners and support from government agencies,” they could potentially begin manufacturing the experimental vaccine in June 2020.